S
Shigehiro Katayama
Researcher at Saitama Medical University
Publications - 251
Citations - 11344
Shigehiro Katayama is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 49, co-authored 251 publications receiving 10637 citations.
Papers
More filters
Journal ArticleDOI
Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population.
Sho Kabasawa,Keisuke Mori,Kuniko Horie-Inoue,Peter L. Gehlbach,Satoshi Inoue,Takuya Awata,Shigehiro Katayama,Shin Yoneya +7 more
TL;DR: In the Japanese population studied, cigarette smoking influenced the risk of AMD but fractionated serum fatty acid levels did not, which is consistent with the high proportion of smokers in aged Japanese men and the high fish oil intake in this population.
Journal ArticleDOI
Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus
TL;DR: The present findings suggest that the acarbose-induced reduction of the postprandial serum insulin or proinsulin responses to food intake might be useful for preventing vascular complications in patients with diabetes.
Journal ArticleDOI
Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study
Hirohito Sone,Sachiko Tanaka,Shiro Tanaka,Satoshi Iimuro,Shun Ishibashi,Shinichi Oikawa,Hitoshi Shimano,Shigehiro Katayama,Yasuo Ohashi,Yasuo Akanuma,Nobuhiro Yamada +10 more
TL;DR: For Japanese diabetic men, non-HDLC and TC/HDLC were the best predictors, whereas TGs were most predictive for women, and should be considered among clinical approaches to risk reduction among East Asians with diabetes.
Journal ArticleDOI
Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress.
TL;DR: The results suggest that the combination of an ARB and an ACEI exerts an additive inhibitory effect, presumably through an increase in production and bioavailability of NO from the endothelium.
Journal ArticleDOI
Combinations of olmesartan and a calciumchannel blocker or a diuretic inelderly hypertensive patients: A randomized, controlled trial
Toshio Ogihara,Takao Saruta,Hiromi Rakugi,Ikuo Saito,Kazuaki Shimamoto,Hiroaki Matsuoka,Kazuyuki Shimada,Sadayoshi Ito,Masatsugu Horiuchi,Tsutomu Imaizumi,Shuichi Takishita,Jitsuo Higaki,Shigehiro Katayama,Genjiroh Kimura,Satoshi Umemura,Nobuyuki Ura,Koichi Hayashi,Masato Odawara,Norio Tanahashi,Toshihiko Ishimitsu,Naoki Kashihara,Satoshi Morita,Satoshi Teramukai +22 more
TL;DR: Despite no significant difference in cardiovascular events, the different safety profiles suggest that the combination of Olmesartan and CCB may be preferable to that of olmesartAn and diuretic.